Bristol-Myers Squibb EPS (Basic) increased by 68.8% to $1.08 in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 80.0%, from $0.60 to $1.08. Over 3 years (FY 2021 to FY 2024), EPS (Basic) shows a downward trend with a 12.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates improved profitability or a reduction in share count, while a decrease suggests declining earnings or equity dilution.
Basic earnings per share represents the portion of a company's profit allocated to each outstanding share of common stoc...
Investors compare this across large-cap technology peers to assess the efficiency of earnings generation relative to the equity base.
is_eps_basic| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.47 | $0.70 | $1.08 | $0.60 | $0.67 | $0.75 | $0.95 | $1.08 | $0.99 | $0.94 | $0.87 | -$5.89 | $0.83 | $0.60 | $0.00 | $1.21 | $0.64 | $1.08 |
| QoQ Change | — | +48.9% | +54.3% | -44.4% | +11.7% | +11.9% | +26.7% | +13.7% | -8.3% | -5.1% | -7.4% | -777.0% | +114.1% | -27.7% | -100.0% | — | -47.1% | +68.8% |
| YoY Change | — | — | — | — | +42.6% | +7.1% | -12.0% | +80.0% | +47.8% | +25.3% | -8.4% | -645.4% | -16.2% | -36.2% | -100.0% | +120.5% | -22.9% | +80.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.